Attention Deficit Hyperactivity Disorder: What Are Pharmacists’ Roles and Associated Outcomes?

Mohamed Hassan Elnaem (), Merna Mahmoud AbouKhatwa, Mahmoud E. Elrggal and Inderpal Singh Dehele
Additional contact information
Mohamed Hassan Elnaem: School of Pharmaceutical Sciences, Universiti Sains Malaysia, Minden 11800, Malaysia
Merna Mahmoud AbouKhatwa: Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Alexandria University, Alexandria 5372066, Egypt
Mahmoud E. Elrggal: College of Pharmacy, Umm Al-Qura University, Makkah 21955, Saudi Arabia
Inderpal Singh Dehele: School of Pharmacy, University of Birmingham, Birmingham B15 2TT, UK

IJERPH, 2023, vol. 20, issue 3, 1-13

Abstract: Globally, the prevalence of attention deficit hyperactivity disorder (ADHD) is increasing. The treatment for ADHD is multifaceted and requires long-term care and support. Pharmacists are capable of assisting patients and their caretakers in achieving desired outcomes. This work discusses and summarizes pharmacists’ roles in ADHD care and their associated outcomes. Overall, pharmacists are positioned to educate on ADHD, optimize medications in a collaborative practice model, manage and monitor side effects, and provide remote and virtual pharmaceutical care. Pharmacists could directly contribute to ensuring medication safety and increasing awareness regarding the optimal use of ADHD medications. Patients with ADHD can benefit from pharmacist involvement in a variety of ways, including, but not limited to, initial screening and referral, the provision of clinical consultation and feedback, and the improvement of self-management and self-awareness of the illness. Pharmacists also play a significant role in therapeutic decision making regarding the initiation, intensification, and monitoring of ADHD treatment to ensure its effectiveness and quality of life improvement. Lastly, pharmacists could help identify more cost-effective treatment approaches for ADHD patients based on the clinical scenario that is encountered.

Keywords: pharmacist; attention deficit hyperactivity disorder; role; pharmaceutical care; outcomes (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2023
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/20/3/2754/pdf (application/pdf)
https://www.mdpi.com/1660-4601/20/3/2754/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:20:y:2023:i:3:p:2754-:d:1057197

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().